Active Pharmaceutical Ingredients
- Industrial Coatings
- Dyes and Pigments
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
- Analytical Chemistry
- Cosmetic Ingredient
- Pharmaceutical Intermediates
01 The ranking has changed, and domestic top pharmaceutical companies have an advantage01 The ranking has changed, and domestic top pharmaceutical companies have an advantage
On April 26, the Henan Provincial Public Resource Trading Center issued the "Notice on Publicizing the Province's Online Drug Transactions in the First Quarter of 2022" (hereinafter referred to as the "Notice")
The "Notice" announced the situation of drug production enterprises and operating enterprises in Henan Province in the first quarter of 2022
The top 10 manufacturers in the top 100 online suppliers in the first quarter are: Chia Tai Tianqing, Jiangsu Hengrui, AstraZeneca, Qilu, Pfizer, Hangzhou Zhongmei Huadong, Shijiazhuang No.
Referring to the pharmaceutical production situation in the first quarter of 2021, Hengrui's ranking has declined, ranking second, with Yangtze River, Bayer Healthcare, and CSPC Ouyi Pharmaceutical falling out of the top ten
Compared with previous years, from the perspective of order and supply amount, different companies have a certain degree of decline
It is worth noting that the ranking of a number of pharmaceutical companies has improved rapidly.
The ranking of Guangzhou Baiyunshan Mingxing Pharmaceutical has improved significantly, and it quickly ranks among the top 20 on the list, ranking 13th.
It can be seen from the ranking of the supply of pharmaceutical companies that under the premise of the normalization of national centralized procurement and the accelerated progress of consistency evaluation, the replacement of original research by generic drugs is gradually accelerating, and the market is quietly changing
02 Henan pharmaceutical business market, the top three are released02 Henan pharmaceutical business market, the top three are released
Among the top 50 distribution companies, China Resources, Sinopharm, and Shanghai Pharmaceuticals are firmly in the top three
The top 10 among the top 50 operating companies in terms of online delivery in the first half of the year are: China Resources Henan Pharmaceutical, Sinopharm Holding Henan Co.
China Resources Henan Pharmaceutical ranked first, with a distribution amount of 1.
03 Announcement of Top 10 Drug Sales03 Announcement of Top 10 Drug Sales
Judging from the top ten drugs by online transaction value in Henan Province in the first quarter of 2022, AstraZeneca's osimertinib tablets topped the list
As a blockbuster drug of AstraZeneca, Osimertinib’s 2021 annual report shows that AstraZeneca’s Osimertinib sales exceeded US$5 billion, a year-on-year increase of 13%
Followed by CSPC Enbipu Pharmaceutical's butylphthalide sodium chloride large infusion; Pfizer's cefoperazone/sulbactam powder injection; Roche's trastuzumab powder injection; Qilu's bevacizumab
The rapid increase in the volume of new tumor drugs has been quickly reflected.
Qilu's bevacizumab, as a biosimilar drug, has sales of 1.
Among the top 10 drug sales in Henan Province in the first quarter, Chia Tai Tianqing has two drugs among them, namely budesonide inhalation suspension and magnesium isoglycyrrhizinate injection
Chia Tai Tianqing's budesonide inhalation suspension achieved a "leap forward" by winning the bid for the fifth batch of centralized procurement.
In the total procurement situation of Henan Province's nationally selected varieties in the first quarter of 2022, the procurement amount of budesonide inhalation was the highest.
83 million yuan
Magnesium isoglycyrrhizinate injection is a Class 1 chemical drug of Chia Tai Tianqing, which has been commercialized long ago and has become a large single product with a level of more than 1 billion
In addition, Henan Province also announced the top 50 pharmaceutical institutions in the first quarter of 2022 by online purchase amount.
The top three are the First Affiliated Hospital of Zhengzhou University, with an order amount of 995 million; Henan Provincial People's Hospital, with an order amount of 639 million; Henan Province Provincial Cancer Hospital, the order amount is 611 million
Overall, in the first quarter of 2022 in Henan Province, a total of 3,665 pharmaceutical institutions (the province's medical institutions and some retail pharmacies), 2,287 manufacturing companies, and 430 operating companies traded through the platform, and traded 13,621 drugs with a transaction amount of 13.
28 billion yuan.
According to the province's online drug transactions in the first quarter of 2021 previously released by Henan Province, a total of 3,388 pharmaceutical institutions (the province's medical institutions and some retail pharmacies), 2,319 manufacturing companies, and 451 operating companies traded through the platform in the first quarter.
16,115 drugs were traded, with a transaction value of 13.
685 billion yuan
In contrast, the number of manufacturing companies, operating companies, and drug transactions and transaction value that participated in the transaction this year decreased, but the number of pharmaceutical institutions increased
The "Notice" pointed out that some pharmaceutical production and operating enterprises did not respond to the purchase orders of medical institutions in a timely manner, and the drug supply rate was low; in terms of implementing the national policy of centralized drug procurement with volume, some pharmaceutical institutions did not return payments in time; the supply rate of selected drugs in individual enterprises low
In the next step, drug production and operation enterprises must regularly check drug inventories, respond to online orders in a timely manner, and ensure sufficient supply